SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001654954-22-011015
Filing Date
2022-08-11
Accepted
2022-08-11 08:12:12
Documents
48
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q mnpr_10q.htm   iXBRL 10-Q 739748
2 CERTIFICATION mnpr_ex311.htm EX-31.1 8142
3 CERTIFICATION mnpr_ex312.htm EX-31.2 9092
4 CERTIFICATION mnpr_ex321.htm EX-32.1 5084
10 mnpr_10qimg1.jpg GRAPHIC 19316
  Complete submission text file 0001654954-22-011015.txt   3306312

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA mnpr-20220630.xsd EX-101.SCH 34631
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE mnpr-20220630_lab.xml EX-101.LAB 207544
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE mnpr-20220630_cal.xml EX-101.CAL 26798
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mnpr-20220630_pre.xml EX-101.PRE 166041
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mnpr-20220630_def.xml EX-101.DEF 82574
42 EXTRACTED XBRL INSTANCE DOCUMENT mnpr_10q_htm.xml XML 472581
Mailing Address 1000 SKOKIE BLVD SUITE 350 WILMETTE IL 60091
Business Address 1000 SKOKIE BLVD SUITE 350 WILMETTE IL 60091 8473880349
Monopar Therapeutics (Filer) CIK: 0001645469 (see all company filings)

IRS No.: 320463781 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39070 | Film No.: 221153790
SIC: 2834 Pharmaceutical Preparations